[Renal involvement in Fabry's disease: diagnosis, follow-up and enzyme replacement therapy].
Renal involvement in Fabry's disease in males starts at an early age with microalbuminuria and proteinuria and progresses rapidly towards end-stage renal disease requiring dialysis or renal transplantation. Renal involvement, together with cardiac and cerebral damage, is responsible for the severe morbidity and mortality in patients with Fabry's disease. In heterozygous female patients renal involvement has also been documented, but the onset of renal damage occurs later and the progression to end-stage renal disease is slower. Considering the relevance of renal damage in the prognosis of Fabry's disease, it is mandatory to point out the diagnostic criteria of Fabry's nephropathy and the modalities of follow-up of patients with renal involvement. The aim of this study is also to provide recommendations regarding the diagnosis, follow-up and indication for enzyme replacement therapy in patients with Fabry's disease.
U.O. Nefrologia e Dialisi, Ospedale degli Infermi, Rimini, Italy. rmignani@auslrn.net
R
R
Mignani
S
S
Feriozzi
G
G
Carraro
F
F
Martinelli
B
B
Cianciaruso
D018450:Disease Progression; D056947:Enzyme Replacement Therapy / Q000379:methods*; D000795:Fabry Disease / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D005500:Follow-Up Studies; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000175:diagnosis* / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D016030:Kidney Transplantation; D017410:Practice Guidelines as Topic; D011379:Prognosis; D006435:Renal Dialysis; D012307:Risk Factors; D012720:Severity of Illness Index; D016896:Treatment Outcome; D000519:alpha-Galactosidase / Q000627:therapeutic use*
D000519:alpha-Galactosidase